logo
Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial Results

Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2025 Financial Results

Business Wire3 days ago
MISSISSAUGA, Ontario--(BUSINESS WIRE)--Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2025 financial results on Wednesday, August 21, 2025, before markets open. A conference call and webcast to discuss the financial results will be held on Wednesday, August 21, 2025, at 8:30am ET.
To view, listen to, and participate in the live webcast, please follow the link below:
https://events.q4inc.com/attendee/481079572
To listen and participate via the conference call, please dial:
North American Toll-Free: 1-800-549-8228
Local (Toronto): 289-819-1520
Local (New York): 646-564-2877
Conference ID: 77702
Participants will be able to ask questions of Company management during the Q&A portion of the conference call either by asking them on the call or by submitting them using the chat function on the webcast.
A recording of the call will be available on www.covalon.com under News & Events on the Investors tab.
Copies of Covalon's financial statements and MD&A can be obtained on SEDAR PLUS at www.sedarplus.ca and under SEDAR Filings on the Investors tab of Covalon's website.
Those interested in learning about Covalon's solutions may visit www.covalon.com or follow Covalon on LinkedIn, Facebook, Instagram, or X.
About Covalon
Covalon is a leading medical device company dedicated to improving patient outcomes through innovative and compassionate medical products and technologies. Our expertise spans advanced wound care, vascular access, and surgical consumables, with a strong focus on enhancing healing, reducing healthcare-associated infections (HAIs), and protecting skin integrity. Our solutions are designed for patients and made for care providers. The Company is listed on the TSX Venture Exchange (COV) and trades on the OTCQX Market (CVALF). To learn more about Covalon, visit our website at www.covalon.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
This news release may contain forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements are often, but not always, identified by the use of words such as 'seek', 'anticipate', 'plan', 'estimate', 'expect', 'intend', or variations of such words and phrases or state that certain actions, events, or results 'may', 'could', 'would', 'might', 'will' or 'will be taken', 'occur', or 'be achieved'. In addition, any statements that refer to expectations, projections or other characterizations of future events or circumstances contain forward-looking information. Statements containing forward-looking information are not historical facts, but instead represent management's expectations, estimates, and projections regarding future events. Forward-looking statements involve risks and uncertainties, including, but not limited to, the factors described in greater detail in the 'Risks and Uncertainties' section of our management's discussion and analysis of financial condition and results of operations for the year ended September 30, 2024, which is available on the Company's profile at www.sedarplus.ca, any of which could cause results, performance, or achievements to differ materially from the results discussed or implied in the forward-looking statements. Investors should not place undue reliance on any forward-looking statements. The forward-looking statements contained in this news release are made as of the date of this news release, and the Company assumes no obligation to update or alter any forward-looking statements, whether as a result of new information, further events, or otherwise, except as required by law.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Earnings playbook: Retail takes center stage with Walmart and Target set to report
Earnings playbook: Retail takes center stage with Walmart and Target set to report

CNBC

time30 minutes ago

  • CNBC

Earnings playbook: Retail takes center stage with Walmart and Target set to report

We're at the tail-end of the earnings season, but there are some major retailers still left to report this week. Walmart , Home Depot and Target are among the companies slated to post quarterly results. The reports will give investors a look at the state of the U.S. consumer. Overall, it's been a strong earnings season. FactSet data shows that, of the more than 460 S & P 500 names that have reported thus far, 82% have beaten bottom-line expectations. Take a look at CNBC Pro's breakdown of what to expect in this week's key reports. All times are ET. Tuesday Home Depot is set to report earnings before the bell, followed by a call at 9 a.m. Last quarter: HD earnings came in below expectations . The company's CFO also said the home improvement retailer would not raise prices due to tariffs. This quarter: Analysts polled by LSEG expect single-digit earnings and revenue growth. What to watch: UBS analyst Michael Lasser expects Home Depot's results to reflect increased demand for its products, but he advised clients to keep an eye on the company's professional segment. "Regarding the pro segment, we believe this continued to provide steady support for the retailer's top-line. HD likely continued to focus on its pro ecosystem, which has been resonating with this customer segment," he said. What history shows: Home Depot exceeds analyst expectations 86% of the time, though the stock only averages a 0.3% advance on earnings days, according to Bespoke Investment Group. Wednesday Target is set to report earnings in the premarket, with management slated to hold a conference call at 8 a.m. Last quarter: TGT cut its sales outlook due to tariff uncertainty and backlash to its DEI rollback. This quarter: Analysts see a year-over-year earnings drop of around 20%, per LSEG. What to watch: Bank of America downgraded the stock last week ahead of earnings, citing a deteriorating outlook. Indeed the stock is down more than 20% year to date. Can Target prove BofA and wary investors wrong with this report? What history shows: Target's earnings top estimates 64% of the time, per Bespoke. Estee Lauder is set to report earnings before the bell. A call with analysts and management is set for 8:30 a.m. Last quarter: EL earnings and revenue came in above expectations, but shares slipped more than 1% due to weak revenue guidance. This quarter: Analysts see steep year-over-year earnings and revenue declines for the cosmetics giant, according to LSEG. What to watch: JPMorgan analyst Andrea Teixeira upgraded Estee Lauder last month, noting she expects the report to be a positive catalyst for the stock. "We are placing EL on Positive Catalyst Watch as we believe EL will positively surprise FQ425 from a revenue standpoint, and while initial guidance for FY26 may be conservative, we believe revenues and margins will continue to improve as retail destocking will likely be behind and the company will have more savings from its PRGP program to reinvest in marketing and innovation," Teixeira wrote on July 25. What history shows: Estee Lauder earnings have beaten analyst expectations for eight straight quarters. However, the stock has fallen after seven of those releases, including one decline of more than 20%. Lowe's is set to report earnings before the bell, followed by a call at 9 a.m. Last quarter: LOW maintained its full-year outlook as sales from home improvement professionals boosted the company's results. This quarter: The company is expected to report earnings growth of less than 5% from the year-earlier period, LSEG data shows. What to watch: "The two wildcards to watch: (i) potential GM upside as higher pricing from tariffs benefit sales, but FIFO accounting delays the cost recognition; and (ii) ADG accretion, which is not in most Street models," Citi analyst Steven Zaccone wrote July 31. What history shows: Earnings days have not been kind to Lowe's recently, with shares falling after the last three quarterly releases. Thursday Walmart is set to report earnings in the premarket, followed by a conference call at 8 a.m. Last quarter: WMT warned of higher prices for customers due to tariffs , while the company beat on earnings. This quarter: LSEG data shows that analysts see year-over-year earnings growth of about 10% for the retail giant. What to watch: "We expect a solid all-around top-line delivery about consistent with the high-end of management's Q2 constant currency sales guidance of +3.5-4.5%. For Walmart US, we are lifting our comp estimate to 4.0% from 3.0% previously. We expect continued momentum in Health & Wellness and Grocery, along with sequentially stronger growth in the General Merchandise category," Oppenheimer analyst Rupesh Parikh wrote. What history shows: Bespoke data shows Walmart earnings top analyst estimates 73% of the time.

Do Daldrup & Söhne's (ETR:4DS) Earnings Warrant Your Attention?
Do Daldrup & Söhne's (ETR:4DS) Earnings Warrant Your Attention?

Yahoo

time5 hours ago

  • Yahoo

Do Daldrup & Söhne's (ETR:4DS) Earnings Warrant Your Attention?

Explore Daldrup & Söhne's Fair Values from the Community and select yours For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to investors, even if it currently lacks a track record of revenue and profit. Sometimes these stories can cloud the minds of investors, leading them to invest with their emotions rather than on the merit of good company fundamentals. A loss-making company is yet to prove itself with profit, and eventually the inflow of external capital may dry up. Despite being in the age of tech-stock blue-sky investing, many investors still adopt a more traditional strategy; buying shares in profitable companies like Daldrup & Söhne (ETR:4DS). Now this is not to say that the company presents the best investment opportunity around, but profitability is a key component to success in business. AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early. How Fast Is Daldrup & Söhne Growing? If a company can keep growing earnings per share (EPS) long enough, its share price should eventually follow. That makes EPS growth an attractive quality for any company. Recognition must be given to the that Daldrup & Söhne has grown EPS by 47% per year, over the last three years. While that sort of growth rate isn't sustainable for long, it certainly catches the eye of prospective investors. One way to double-check a company's growth is to look at how its revenue, and earnings before interest and tax (EBIT) margins are changing. Daldrup & Söhne shareholders can take confidence from the fact that EBIT margins are up from 2.9% to 12%, and revenue is growing. That's great to see, on both counts. In the chart below, you can see how the company has grown earnings and revenue, over time. Click on the chart to see the exact numbers. Check out our latest analysis for Daldrup & Söhne Of course the knack is to find stocks that have their best days in the future, not in the past. You could base your opinion on past performance, of course, but you may also want to check this interactive graph of professional analyst EPS forecasts for Daldrup & Söhne. Are Daldrup & Söhne Insiders Aligned With All Shareholders? Theory would suggest that it's an encouraging sign to see high insider ownership of a company, since it ties company performance directly to the financial success of its management. So as you can imagine, the fact that Daldrup & Söhne insiders own a significant number of shares certainly is appealing. Indeed, with a collective holding of 58%, company insiders are in control and have plenty of capital behind the venture. This should be seen as a good thing, as it means insiders have a personal interest in delivering the best outcomes for shareholders. In terms of absolute value, insiders have €45m invested in the business, at the current share price. So there's plenty there to keep them focused! Is Daldrup & Söhne Worth Keeping An Eye On? Daldrup & Söhne's earnings per share have been soaring, with growth rates sky high. That EPS growth certainly is attention grabbing, and the large insider ownership only serves to further stoke our interest. The hope is, of course, that the strong growth marks a fundamental improvement in the business economics. Based on the sum of its parts, we definitely think its worth watching Daldrup & Söhne very closely. Even so, be aware that Daldrup & Söhne is showing 3 warning signs in our investment analysis , you should know about... Although Daldrup & Söhne certainly looks good, it may appeal to more investors if insiders were buying up shares. If you like to see companies with more skin in the game, then check out this handpicked selection of German companies that not only boast of strong growth but have strong insider backing. Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Cory Morgan: Cities Should Halt Electric Bus Purchases Given Their Abysmal Track Record
Cory Morgan: Cities Should Halt Electric Bus Purchases Given Their Abysmal Track Record

Epoch Times

time6 hours ago

  • Epoch Times

Cory Morgan: Cities Should Halt Electric Bus Purchases Given Their Abysmal Track Record

While the political battle rages on over mandates for consumer purchases of electric vehicles, Canadian municipalities have been going all-in on electric buses, and it hasn't gone well. Despite the failures of electric bus fleets in numerous North American cities, local governments continue to commit to large-scale electric bus purchases. Calgary's recent commitment to spend nearly half a billion dollars on a fleet of electric buses is one of the latest and largest expenditures in Canada.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store